Bactiguard

Bactiguard is a global, publicly traded MedTech company with a unique and clinically proven infection prevention platform. Its core business model involves licensing its patented noble metal coating technology to leading medical device manufacturers, who integrate it into their products such as catheters and implants. With over 40 clinical studies supporting its efficacy, the technology addresses a critical unmet need in healthcare by reducing infections, improving patient outcomes, and lowering system costs. The company complements this licensing revenue with direct sales of its wound management products.

Patented ultra-thin coating of gold, silver, and palladium alloy applied to medical devices. Creates a minute galvanic effect in contact with fluids to prevent microbial adhesion and biofilm formation, reducing device-related infections.

Bactiguard competes with other companies developing antimicrobial coatings (e.g., using antibiotics, silver ions, other metals) and with device manufacturers' in-house technologies. Its differentiation lies in its specific noble metal alloy, strong clinical evidence base, biocompatibility profile, and established partnerships with major MedTech firms.